Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05123742 · ClinicalTrials.gov registry record
PREDICT: A PBRN Feasibility Study on COVID-19 Screening in Dental Practice
A clinical trial of COVID-19 Infection, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- 72
- Enrollment target
- 1
- Study location
NCT05123742: Completed study of COVID-19 Infection, sponsored by Rutgers, The State University of New Jersey.
NCT05123742 is a study of COVID-19 Infection that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 72 participants, below the 3,148-participant average among 21 other COVID-19 Infection trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05123742, a study of COVID-19 Infection, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- 72 participants
- Enrollment target
- 1
- Study location
Study Summary
The study team will conduct a feasibility study to develop and test out procedures for improved triage and COVID-19 testing in dental practices to increase safety and perceptions of the safety of Dental Health Care Workers (DHCW) and their patients. DHCWs in offices with Practice-Based Regional Network (PBRN) members and their patients will be recruited to participate in one of two protocols. The first, point-of-care (POC), will test out procedures for point-of-care SARS-CoV-2 antigen testing in the dental office along with enhanced triage using pulse oximeters. The second, laboratory (LAB), will test out procedures for a saliva-based laboratory SARS-CoV-2 viral test along with enhanced triage. The feasibility of implementing COVID-related testing and enhanced triage procedures in the dental setting will provide preliminary data to inform a larger network-wide study grant application.
Primary Outcome
Participants perception of safety in the dental office. Outcome measure is a score on a scale from 0 to 100 where 0=has unsafe as one can possibly feel and 100=as safe as one can possibly feel. All participants (DHCW and patients) were asked to indicate how safe they would feel seeking dental care if all dental office workers, but not patients, were regularly tested: how safe they would feel seeking care if all patients, but not dental care workers, were tested prior to their dental appointments
Conditions Studied
Interventions
- DIAGNOSTIC_TEST COVID-19 Testing
Study Locations (1)
New Jersey
- Rutgers School of Dental Medicine - Newark
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2021-12-13 |
| Est. Completion | 2022-12-31 |
What the finished NCT05123742 record still lists
NCT05123742 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 3,148-participant average among 21 other COVID-19 Infection trials with a reported enrollment target (98% lower).
The record links to 1 condition, with COVID-19 Infection appearing as the primary indexed condition, and to 1 intervention - of which COVID-19 Testing is the first listed.
NCT05123742 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT05123742 about?
NCT05123742 is a clinical study titled "PREDICT: A PBRN Feasibility Study on COVID-19 Screening in Dental Practice". The study team will conduct a feasibility study to develop and test out procedures for improved triage and COVID-19 testing in dental practices to increase safety and perceptions of the safety of Dental Health Care Workers (DHCW) and their patients. DHCWs in offices with Practice-Based Regional Netw...
What is the current status of trial NCT05123742?
This trial is currently completed. The enrollment target is 72 participants. The study started on 2021-12-13. Estimated completion is 2022-12-31.
What conditions does trial NCT05123742 study?
This clinical trial studies the following conditions: COVID-19 Infection.
What interventions are being tested in trial NCT05123742?
The interventions under investigation include: COVID-19 Testing (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05123742?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05123742 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19 Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05123742's enrollment target sits among peer trials
72 19th of 21 higher than 3 of 21 other COVID-19 Infection trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other COVID-19 Infection trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Send-In Sample Collection for Comprehensive Analyses of Innate and Adaptive Immune Responses During Acute COVID-19 and Convalescence
RECRUITING
-
Researchers At UC San Diego Are Learning About the Benefits of Human Milk and How It Influences Infant and Child Health
RECRUITING
-
A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia
RECRUITING · Phase 2
-
The Impact of COVID-19 on Pulmonary Procedures
RECRUITING
-
Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic
RECRUITING
-
Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI